By addressing the unethical practices surrounding BPC-157, we can protect patient safety and uphold the integrity of medical practice
doi:10.1371/journal.pone.0033944 Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ et al (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
SLU-PP-332 SLU-PP-332 is a synthetic small-molecule ERR (estrogen-related receptor) pan-agonist under investigation for its role in mitochondrial biogenesis, skeletal muscle fiber-type switching, and metabolic regulation
Peptides may benefit sleep quality by promoting the release of hormones such as melatonin and interacting with the various phases of sleep